© Copyright 2026, All Rights Reserved
Venture investor in deep tech and life sciences with University of Cambridge ties
Funding AI startups developing quantum error correction; Investing in medtech companies with precision microbiome therapies; Supporting semiconductor startups in advanced manufacturing; Backing therapeutics with clinical trial advancements; Providing growth funding to life sciences companies in genomics and digital health
Manages £500M+ in assets; Invested in >30 companies; Backed by University of Cambridge; £3.1bn co-investment capital; Recognized in Fierce Biotech’s 'Fierce 15' for 2025; Portfolio includes FDA-indicated therapeutics and quantum computing platforms